Abstract
In our previous study, we observed that the presence of autoimmune thyroid disease worsens fibromyalgia (FM) symptoms. The aims of this study are to evaluate whether there is a predisposition for the development of FM in patients with Hashimoto’s thyroiditis (HT) with or without subclinical hypothyroidism (SCH) and in patients with SCH alone and what is the weight of antithyroid antibody positivity and SCH on FM comorbidity. Fifty-two patients, 39 affected by HT with or without SCH and 13 by SCH, were matched with 37 patients affected by FM and 25 healthy subjects. Blood samples were collected from all study subjects for the determination of serum TSH, free triiodothyronine, free thyroxine, antithyroperoxidase antibody (TPOAb), antithyroglobulin antibody (TgAb) and non-organ-specific autoantibodies. Clinical assessment of patients and controls included the “Fibromyalgia Impact Questionnaire” (FIQ), while pain severity was evaluated using a visual analogue scale (VAS). Patients and controls were also characterized by the presence of diffuse pain, fatigue, paresthesiae, muscle spasms, non-restful sleep, tension headache and presence of mood disorders. FM comorbidity resulted in twelve HT subjects (31%) and none in SCH patient. In particular, FM comorbidity in HT patients without SCH was 33.3% and in HT patients with SCH was 28.5%. Based on our data, we speculate that maybe there is more than a hypothesis regarding the cause–effect relation between thyroid autoimmunity and the presence of FM, thus suggesting a hypothetical role of thyroid autoimmunity in FM pathogenesis.
Similar content being viewed by others
References
Breivik H, Collett B, Ventafridda V, Cohen R, Gallacher D (2006) Survey of chronic pain in Europe: prevalence, impact on daily life, and treatment. Eur J Pain 10:287–333
Wolfe F, Smythe HA, Yunus MB, Bennett RM, Bombardier C, Goldenberg DL, Tugwell P, Campbell SM, Abeles M, Clark P et al (1990) The American College of Rheumatology 1990 criteria for the classification of fibromyalgia. Report of the multicenter criteria committee. Arthritis Rheum 33:160–172
Ablin J, Neumann L, Buskila D (2008) Pathogenesis of fibromyalgia—a review. Joint Bone Spine 75:273–279
Stisi S, Cazzola M, Buskila D, Spath M, Giamberardino MA, Sarzi-Puttini P, Arioli G, Alciati A, Leardini G, Gorla R, et al. (2008) Italian Fibromyalgia Network. Etiopathogenetic mechanisms of fibromyalgia syndrome. Reumatismo 60 Suppl 1:25–35
Tanriverdi F, Karaca Z, Unluhizarci K, Kelestimur F (2007) The hypothalamo-pituitary-adrenal axis in chronic fatigue syndrome and fibromyalgia syndrome. Stress 10:13–25
Calis M, Gökçe C, Ates F, Ulker S, Izgi HB, Demir H, Kirnap M, Sofuoglu S, Durak AC, Tutus A, Kelestimur F (2004) Investigation of the hypothalamo-pituitary-adrenal axis (HPA) by 1 microg ACTH test and metyrapone test in patients with primary fibromyalgia syndrome. J Endocrinol Invest 27:42–46
Bazzichi L, Dini M, Rossi A, Corbianco S, De Feo F, Giacomelli C, Zirafa C, Ferrari C, Rossi B, Bombardieri S (2009) Muscle modifications in fibromyalgic patients revealed by surface electromyography (SEMG) analysis. BMC Musculoskelet Disord 10:36
Bazzichi L, Palego L, Giannaccini G, Rossi A, De Feo F, Giacomelli C, Betti L, Giusti L, Mascia G, Bombardieri S, Lucacchini A (2009) Altered amino acid homeostasis in subjects affected by fibromyalgia. Clin Biochem 42:1064–1070
Bazzichi L, Giannaccini G, Betti L, Fabbrini L, Schmid L, Palego L, Giacomelli C, Rossi A, Giusti L, De Feo F, Giuliano T, Mascia G, Bombardieri S, Lucacchini A (2008) ATP, calcium and magnesium levels in platelets of patients with primary fibromyalgia. Clin Biochem 41:1084–1090
Bazzichi L, Giacomelli C, De Feo F, Giuliano T, Rossi A, Doveri M, Tani C, Wilson RB, Bombardieri S (2007) Antipolymer antibody in Italian fibromyalgic patients. Arthritis Res Ther 9:R86
Bazzichi L, Rossi A, Massimetti G, Giannaccini G, Giuliano T, De Feo F, Ciapparelli A, Dell’Osso L, Bombardieri S (2007) Cytokine patterns in fibromyalgia and their correlation with clinical manifestations. Clin Exp Rheumatol 25:225–230
Salvetti G, Manfredini D, Bazzichi L, Bosco M (2007) Clinical features of the stomatognathic involvement in fibromyalgia syndrome: a comparison with temporomandibular disorders patients. Cranio 25:127–133
Bazzichi L, Rossi A, Giuliano T, De Feo F, Giacomelli C, Consensi A, Ciapparelli A, Consoli G, Dell’osso L, Bombardieri S (2007) Association between thyroid autoimmunity and fibromyalgic disease severity. Clin Rheumatol 26:2115–2120
Bazzichi L, Giannaccini G, Betti L, Italiani P, Fabbrini L, Defeo F, Giacomelli C, Giuliano T, Rossi A, Uccelli A, Giusti L, Mascia G, Lucacchini A, Bombardieri S (2006) Peripheral benzodiazepine receptors on platelets of fibromyalgic patients. Clin Biochem 39:867–872
Bazzichi L, Giannaccini G, Betti L, Mascia G, Fabbrini L, Italiani P, De Feo F, Giuliano T, Giacomelli C, Rossi A, Lucacchini A, Bombardieri S (2006) Alteration of serotonin transporter density and activity in fibromyalgia. Arthritis Res Ther 8:R99
Arnold LM (2009) Pain and the brain: chronic widespread pain. J Clin Psychiatry 70:e10
Verheesen RH, Schweitzer CM (2008) Iodine deficiency, more than cretinism and goiter. Med Hypotheses 71:645–648
Lowe JC, Yellin J, Honeyman-Lowe G (2006) Female fibromyalgia patients: lower resting metabolic rates than matched healthy controls. Med Sci Monit 12:CR282-9
Reilly PA (1999) The differential diagnosis of generalized pain. Baillieres Best Pract Res Clin Rheumatol 13:391–401
Golding DN (1970) Hypothyroidism presenting with musculoskeletal symptoms. Ann Rheum Dis 29:10–14
Wilke WS, Sheeler LR, Makarowski WS (1981) Hypothyroidism with presenting symptoms of fibrositis. J Rheumatol 8:626–631
First MB, Spitzer RL, Gibbon M et al (1997) Structured clinical interview for DSM-IV Axis I (SCID-I). clinician version. American Psychiatric Press, Washington, DC
Sonkin LS (1985) Endocrine disorders and muscle dysfunction. In: Gelb B (ed) Clinical management of Head Neck and TMJ Pain and Dysfunction. WB Saunders Co, Philadelphia, pp 137–170
Sarzi-Puttini P, Atzeni F, Fiorini T, Panni B, Randisi G, Turiel M, Carrabba M (2003) Validation of an Italian version of the Fibromyalgia Impact Questionnaire (FIQ-I). Clin Exp Rheumatol 21:459–464
Dictionary of the Rheumatic Diseases: Signs and Symptoms (1988) Vol.1 prepared by ARA glossary Commettee American Rheumatism Associations third edition
Webster’s New World Medical Dictionary (2003) second edition
Ruffatti A, Calligaro A, Ferri C, Bombardieri S, Gambari PF, Todesco S (1985) Association of anti-centromere and anti-Scl 70 antibodies in scleroderma. Report of two cases. J Clin Lab Immunol 16:227–229
Mosca M, Tani C, Bombardieri S (2008) A case of undifferentiated connective tissue disease: is it a distinct clinical entity? Nat Clin Pract Rheumatol 4:328–332
Pratesi F, Tommasi C, Anzilotti C, Chimenti D, Migliorini P (2006) Deiminated Epstein-Barr virus nuclear antigen 1 is a target of anti-citrullinated protein antibodies in rheumatoid arthritis. Arthritis Rheum 54:733–741
Soy M, Guldiken S, Arikan E, Altun BU, Tugrul A (2007) Frequency of rheumatic diseases in patients with autoimmune thyroid disease. Rheumatol Int 27:575–577
Karsh J, Pavlidis N, Weintraub BD, Moutsopoulos HM (1980) Thyroid disease in Sjögren’s syndrome. Arthritis Rheum 23:1326–1329
Pyne D, Isenberg DA (2002) Autoimmune thyroid disease in systemic lupus erythematosus. Ann Rheum Dis 61:70–72
Pérez B, Kraus A, López G, Cifuentes M, Alarcón-Segovia D (1995) Autoimmune thyroid disease in primary Sjögren’s syndrome. Am J Med 99:480–484
Jenkins RC, Weetman AP (2002) Disease associations with autoimmune thyroid disease. Thyroid 12:977–988
Bizzaro N (2008) The predictive significance of autoantibodies in organ-specific autoimmune diseases. Clin Rev Allergy Immunol 34:326–331
Carlé A, Laurberg P, Knudsen N, Perrild H, Ovesen L, Rasmussen LB, Jorgensen T, Pedersen IB (2006) Thyroid peroxidase and thyroglobulin auto-antibodies in patients with newly diagnosed overt hypothyroidism. Autoimmunity 39:497–503
Rapoport B, McLachlan SM (2001) Thyroid autoimmunity. J Clin Invest 108:1253–1259
Tomer Y (1997) Anti-thyroglobulin autoantibodies in autoimmune thyroid diseases: cross-reactive or pathogenic? Clin Immunol Immunopathol 82:3–11
Nielsen CH, Leslie RG, Jepsen BS, Kazatchkine MD, Kaveri SV, Fischer E (2001) Natural autoantibodies and complement promote the uptake of a self antigen, human thyroglobulin, by B cells and the proliferation of thyroglobulin-reactive CD4(+) T cells in healthy individuals. Eur J Immunol 31:2660–2668
Jensen EA, Petersen PH, Blaabjerg O, Hansen PS, Brix TH, Hegedüs L (2006) Establishment of reference distributions and decision values for thyroid antibodies against thyroid peroxidase (TPOAb), thyroglobulin (TgAb) and the thyrotropin receptor (TRAb). Clin Chem Lab Med 44:991–998
Vanderpump MP, Tunbridge WM, French JM, Appleton D, Bates D, Clark F, Grimley Evans J, Hasan DM, Rodgers H, Tunbridge F et al (1995) The incidence of thyroid disorders in the community: a twenty-year follow-up of the Whickham Survey. Clin Endocrinol (Oxf) 43:55–68
Monzani F, Caraccio N, Del Guerra P, Casolaro A, Ferrannini E (1999) Neuromuscular symptoms and dysfunction in subclinical hypothyroid patients: beneficial effect of L-T4 replacement therapy. Clin Endocrinol (Oxf) 51:237–242
Ruchala M, Kosowicz J, Baumann-Antczak A, Skiba A, Zamyslowska H, Sowinski J (2007) The prevalence of autoantibodies to: myosin, troponin, tropomyosin and myoglobin in patients with circulating triiodothyronine and thyroxine autoantibodies (THAA). Neuro Endocrinol Lett 28:259–266
Sinaii N, Cleary SD, Ballweg ML, Nieman LK, Stratton P (2002) High rates of autoimmune and endocrine disorders, fibromyalgia, chronic fatigue syndrome and atopic diseases among women with endometriosis: a survey analysis. Hum Reprod 17:2715–2724
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Bazzichi, L., Rossi, A., Zirafa, C. et al. Thyroid autoimmunity may represent a predisposition for the development of fibromyalgia?. Rheumatol Int 32, 335–341 (2012). https://doi.org/10.1007/s00296-010-1620-1
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00296-010-1620-1